SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 133 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $978,216 | -43.0% | 252,769 | -12.3% | 0.00% | -50.0% |
| Q2 2023 | $1,717,398 | -0.4% | 288,154 | -45.3% | 0.00% | 0.0% |
| Q1 2023 | $1,723,892 | -30.3% | 527,184 | -15.8% | 0.00% | -33.3% |
| Q4 2022 | $2,473,478 | -23.2% | 626,197 | +16.7% | 0.00% | -25.0% |
| Q3 2022 | $3,220,000 | +3.3% | 536,717 | +10.7% | 0.00% | 0.0% |
| Q2 2022 | $3,117,000 | +56.9% | 484,795 | +101.5% | 0.00% | +100.0% |
| Q1 2022 | $1,987,000 | -55.4% | 240,549 | -16.5% | 0.00% | -50.0% |
| Q4 2021 | $4,460,000 | -20.0% | 288,101 | +16.4% | 0.00% | -20.0% |
| Q3 2021 | $5,576,000 | – | 247,589 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
| Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
| Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
| Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
| Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
| SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
| HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
| Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
| Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |